MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 161 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $884,000 | -24.2% | 52,290 | -40.2% | 0.35% | -8.5% |
Q1 2017 | $1,166,000 | +330.3% | 87,377 | +277.0% | 0.38% | +481.5% |
Q3 2016 | $271,000 | -85.7% | 23,178 | -86.8% | 0.06% | -81.4% |
Q2 2016 | $1,897,000 | +112.9% | 175,677 | +82.3% | 0.35% | +172.7% |
Q1 2016 | $891,000 | -66.3% | 96,386 | -45.9% | 0.13% | -55.1% |
Q4 2015 | $2,644,000 | +499.5% | 178,161 | +563.3% | 0.28% | +562.8% |
Q3 2015 | $441,000 | -47.4% | 26,859 | -26.9% | 0.04% | -47.6% |
Q2 2015 | $838,000 | +164.4% | 36,743 | +75.9% | 0.08% | +164.5% |
Q1 2015 | $317,000 | +18.3% | 20,884 | -6.3% | 0.03% | +19.2% |
Q4 2014 | $268,000 | -11.0% | 22,277 | -16.1% | 0.03% | 0.0% |
Q3 2014 | $301,000 | -46.0% | 26,564 | -42.4% | 0.03% | -40.9% |
Q2 2014 | $557,000 | -7.8% | 46,150 | -11.0% | 0.04% | +10.0% |
Q1 2014 | $604,000 | -51.0% | 51,833 | -25.7% | 0.04% | -31.0% |
Q4 2013 | $1,233,000 | +65.7% | 69,755 | +34.9% | 0.06% | +70.6% |
Q3 2013 | $744,000 | +74.2% | 51,726 | +82.5% | 0.03% | +88.9% |
Q2 2013 | $427,000 | – | 28,346 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |